Skip to main content

Cell and gene therapy based approaches for treatment of Parkinson's disease: from models to clinics

Objective

Parkinson s disease is one of the common causes of disability in the aging population, representing a major health problem for the affected individuals and a socioeconomic burden to the society. In the present proposal, the applicant puts forward an ambitious but feasible program to tackle a number of significant issues that remain unsolved in the field. He combines his strong track record in animal models of Parkinson s disease and novel cell and gene therapy-based therapeutic strategies with powerful bio-imaging techniques in order to make bold steps towards translation of new and better treatments to patients suffering from this illness. He does so in a manner that combines, on one hand, the strength of clearly-defined hypotheses and well-established tools for results towards clinical translation, with high-risk high-reward projects that hold the potential to yield ground-breaking discoveries in implementation of novel imaging techniques, on the other.

Field of science

  • /medical and health sciences/basic medicine/neurology/parkinson
  • /medical and health sciences/medical biotechnology/genetic engineering/gene therapy

Call for proposal

ERC-2009-StG
See other projects for this call

Funding Scheme

ERC-SG - ERC Starting Grant

Host institution

MAX IV Laboratory, Lund University
Address
Paradisgatan 5C
22100 Lund
Sweden
Activity type
Higher or Secondary Education Establishments
EU contribution
€ 1 508 940
Principal investigator
Deniz Kirik (Prof.)
Administrative Contact
Deniz Kirik (Prof.)

Beneficiaries (1)

MAX IV Laboratory, Lund University
Sweden
EU contribution
€ 1 508 940
Address
Paradisgatan 5C
22100 Lund
Activity type
Higher or Secondary Education Establishments
Principal investigator
Deniz Kirik (Prof.)
Administrative Contact
Deniz Kirik (Prof.)